Applying The 10x Strategy To Clinical Trials: How Every New Treatment Can Move At Warp Speed

By John Potthoff, Ph.D., CEO

Imagine how many lives would be saved if we were able to develop treatments at warp speed instead of the years it typically takes before a medicine is approved? On March 17, 2020, Pfizer and BioNTech partnered to jointly develop a COVID-19 vaccine. Within a month and a half of their announcement, four volunteers in Germany were dosed with the vaccine. By December 14, 2020, citizens in the U.S. received their first dose. The COVID-19 vaccine showed us we can develop products and take them to market faster.

So, the question becomes, “Why aren’t we developing all new therapies at warp speed?” Isn’t someone with asthma or psoriasis or a child with a rare condition deserving of a warp-speed attempt? How can we accelerate all clinical trials by 10 times?